In addition, Tregs isolated from DLBCL patients showed an upregulation of molecules, such as CCR5, CCR8, and CCR10, directing cells toward DLBCL infiltrating tissues. The gene discussed is CCR5; the disease is diffuse large B-cell lymphoma.